2019
DOI: 10.1016/j.procbio.2018.12.032
|View full text |Cite
|
Sign up to set email alerts
|

Effect of redox mediators in pharmaceuticals degradation by laccase: A comparative study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
29
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
2
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 74 publications
(34 citation statements)
references
References 56 publications
2
29
0
3
Order By: Relevance
“…the micropollutant solution. After 48h, no significant bio-oxidation was observed for any pharmaceutical confirming the recalcitrance of these micropollutants to laccase degradation, as already reported with free enzymes by Parra Guardado et al (2019). These authors attributed the low removal to the complex chemical structure of the compounds.…”
Section: Oxidation Of Pharmaceuticals By Immobilized Laccasesupporting
confidence: 76%
See 1 more Smart Citation
“…the micropollutant solution. After 48h, no significant bio-oxidation was observed for any pharmaceutical confirming the recalcitrance of these micropollutants to laccase degradation, as already reported with free enzymes by Parra Guardado et al (2019). These authors attributed the low removal to the complex chemical structure of the compounds.…”
Section: Oxidation Of Pharmaceuticals By Immobilized Laccasesupporting
confidence: 76%
“…Nevertheless, the depletion of recalcitrant micropollutants needs the addition of redox mediators. When they react with laccase, these mediators lead to highly reactive and stable radical species, thus reacting with micropollutants (Parra Guardado et al 2019). Despite all advantages of enzymatic treatment of wastewaters, the use of laccases in environmental applications presents some drawbacks related to their limited stability in solution, difficult recovery, and reusability, resulting in high operational costs.…”
Section: Introductionmentioning
confidence: 99%
“…Anti‐inflammatory drugs, antiepileptic and antidepressants are present in high concentration in wastewater and are challenging to be removed completely due to their physicochemical properties and resistance towards biological attack . Laccase enzymes can catalyze oxidation–reduction reactions to efficiently biodegrade some of these contaminants in a very efficient way and have been widely studied to improve the biodegradation of pharmaceutical contaminants (Table ) . The structure of the toxic compound will determine its toxicity degree and the appropriated laccase to be used for its degradation.…”
Section: Laccases As Versatile Enzymes: Traditional and New Industriamentioning
confidence: 99%
“…This system has great potential to be used as an alternative for PAHs treatment [12]. Specifically, laccase (EC: 1.10.3.2), the simplest copper-containing (T1, T2 and binuclear T3 copper atom) polyphenol oxidase, which could oxidize a wide range of aromatic and nonaromatic compounds via continuous single-electron oxidation processes stimulated by the unique redox ability of copper ions [13]. However, there are two main problems in the catalytic processes of laccase: the first one is the low redox potential of the T1 copper atom as a direct electron acceptor, which limits its catalytic activities for many refractory organic compounds [14]; the other one is the reusability of laccase, which leads to large amount of reagents waste [10].…”
Section: Introductionmentioning
confidence: 99%